Prediction of paclitaxel sensitivity by CDK1 and CDK2 activity in human breast cancer cells - Nakayama, Satoshi; Torikoshi, Yasuhiro; Takahashi, Takeshi; Yoshida, Tomokazu; Sudo, Tamotsu; Matsushima, Tomoko; Kawasaki, Yuko; Katayama, Aya; Gohda, Keigo; Hortobagyi, Gabriel N; Noguchi, Shinzaburo; Sakai, Toshiyuki; et al. (Breast cancer research : BCR, 2009)
Keywords: Animals; Antineoplastic Agents, Phytogenic - pharmacology; Breast cancer; Breast Neoplasms - drug therapy; Breast Neoplasms - enzymology; Breast Neoplasms - pathology; CDC2 Protein Kinase - metabolism; Cell Cycle - drug effects; Chromatin - metabolism; Cyclin-Dependent Kinase 2 - metabolism; DNA, Neoplasm - genetics; DNA, Neoplasm - metabolism; Dosage and administration; Drug Resistance, Neoplasm; Drug therapy; Female; Genetic aspects; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Paclitaxel; Paclitaxel - pharmacology; Physiological aspects; Protein kinases; Tumor Cells, Cultured; Xenograft Model Antitumor Assays; United States; Japan